Yahoo Web Search

Search results

1. www.nature.com › articles › s43018/023/00569-0Breathing room – focusing on the ‘other’ lung cancer

   www.nature.com › articles › s43018/023/00569-0

   May 25, 2023 · Charles Rudin completed his MD, PhD, medical and oncology training at the University of Chicago, where he joined the department of medicine faculty in 1998. He directed the lung, esophageal and...

   • Author: Charles M. Rudin

   • Email: rudinc@mskcc.org

2. www.mskcc.org › research-areas › labsThe Charles Rudin Lab - Memorial Sloan Kettering Cancer Center

   www.mskcc.org › research-areas › labs

   • Cached

   Charles M. Rudin, MD, PhD. Physician-scientist Charles M. Rudin, Chief of the Thoracic Oncology Service, leads research that focuses on the development and testing of novel therapeutic approaches to lung cancer in preclinical models including patient-derived xenografts.

   • 
   • 
   • 
   • 

3. scholar.google.com › citations‪Charles Rudin‬ - ‪Google Scholar‬

   scholar.google.com › citations

   • Cached

   Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. CM Rudin, S Durinck, EW Stawiski, JT Poirier, Z Modrusan, DS Shames, ... Nature genetics...

4. www.mskcc.org › cancer-care › doctorsCharles M. Rudin, MD, PhD - MSK Thoracic Medical Oncologist

   www.mskcc.org › cancer-care › doctors

   • Cached

   I am a board-certified medical oncologist specializing in the care of patients with lung cancer. I serve as MSK’s Cancer Center Deputy Director. I am also co-chair of the Eastern Cooperative Oncology Group Thoracic Committee, and a member of the National Cancer Institute Thoracic Malignancies Steering Committee.

5. www.onclive.com › view › dr-rudin-on-expansion-ofDr. Rudin on Expansion of Immunotherapy in Lung Cancer

   www.onclive.com › view › dr-rudin-on-expansion-of

   • Cached

   Aug 8, 2019 · Rudin wants to expand the utility of immunotherapy to allow more patients to experience the durable, long-term benefit that some patients are able to achieve.

6. gradschool.weill.cornell.edu › faculty › charles-rudinCharles Rudin | Graduate School of Medical Sciences

   gradschool.weill.cornell.edu › faculty › charles-rudin

   • Cached

   Dr. Charles M. Rudin, completed his MD/PhD training in the MSTP Program of the Pritzker School of Medicine at the University of Chicago, with thesis work under the mentorship of molecular immunologist Ursula Storb.

7. People also ask

   Who is Charles Rudin?

   • Charles Rudin completed his MD, PhD, medical and oncology training at the University of Chicago, where he joined the department of medicine faculty in 1998. He directed the lung, esophageal and head and neck cancer program at Johns Hopkins University from 2003 to 2013, while also serving as associate cancer center director for clinical research.

   Breathing room – focusing on the ‘other’ lung cancer - Nature

   www.nature.com/articles/s43018-023-00569-0

   See all results for this question

   Where did Dr Rudin go to college?

   • He stayed at Chicago for residency, fellowship, post-doctoral training in the cancer biology laboratory of Craig Thompson, and his first faculty job. Dr. Rudin moved to Johns Hopkins University as the founding co-Director of the Upper Aerodigestive Cancer Program, and served as Associate Cancer Center Director for Clinical Research.

   Charles Rudin | Graduate School of Medical Sciences

   gradschool.weill.cornell.edu/faculty/charles-rudin

   See all results for this question

   Does Dr Rudin see patients at a different location?

   • Dr. Rudin sees patients at one location. Leaflet © OpenStreetMap contributors; © CARTO. Looking to see a doctor at a different location? See all MSK locations . Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

   Charles M. Rudin, MD, PhD - MSK Thoracic Oncologist

   www.mskcc.org/cancer-care/doctors/charles-rudin

   See all results for this question

   What is the Rudin lab?

   • The Rudin Lab explores lung cancer therapeutic vulnerabilities, tumor cell intrinsic and extrinsic, to define better approaches to the treatment of this disease. We are interested in defining better therapeutic approaches to the treatment of lung cancer patients.

   Charles Rudin | Graduate School of Medical Sciences

   gradschool.weill.cornell.edu/faculty/charles-rudin

   See all results for this question

   How do I schedule an appointment with Dr Rudin?

   • Scheduling an appointment is easy. Click or call 646-497-9163 — we’re available Monday through Friday, 8 a.m. to 6 p.m. (Eastern time) Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID. Dr. Rudin sees patients at one location.

   Charles M. Rudin, MD, PhD - MSK Thoracic Oncologist

   www.mskcc.org/cancer-care/doctors/charles-rudin

   See all results for this question

   Who does Charles M Rudin disclose?

   • Charles M. Rudin discloses the following relationships and financial interests: If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor. The information published here is for a specific annual disclosure period.

   Charles M. Rudin, MD, PhD - MSK Thoracic Oncologist

   www.mskcc.org/cancer-care/doctors/charles-rudin

   See all results for this question

8. www.mskcc.org › research-areas › labsCharles M. Rudin: Featured News | Memorial Sloan Kettering ...

   www.mskcc.org › research-areas › labs

   • Cached

   Oct 15, 2020 · During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).